Effect of a controlled-release chlorhexidine chip on clinical and microbiological parameters and prostaglandin E2 levels in gingival crevicular fluid

Journal of Periodontology

Volumn 77, Issue 3, 2006, Pages 437-443

  Mizrak, Tansel ^a   Güncü, Güliz N ^b   Çaǧlayan, Feriha ^b   Balci, Tansel Ansal ^c   Aktar, Gülseren Samanci ^a   Ipek, Fikret ^a  

^a DICLE UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

^c FIRAT UNIVERSITY   (Turkey)

Author keywords

Chlorhexidine therapeutic use; Drug delivery systems; Gingival crevicular fluid analysis; Prostaglandin E

Indexed keywords

CHLORHEXIDINE; GELATIN; PROSTAGLANDIN E2; CHLORHEXIDINE GLUCONATE; DRUG DERIVATIVE; TOPICAL ANTIINFECTIVE AGENT;

ADULT; ARTICLE; BIODEGRADABLE IMPLANT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG DELIVERY SYSTEM; FEMALE; FOLLOW UP; GINGIVITIS; HUMAN; MALE; MICROBIOLOGICAL EXAMINATION; PARALLEL DESIGN; PERIODONTITIS; PREVENTIVE DENTISTRY; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SPIROCHETE; TREATMENT RESPONSE; ANAEROBIC BACTERIUM; CHEMISTRY; CHRONIC DISEASE; DELAYED RELEASE FORMULATION; DRUG EFFECT; METABOLISM; MICROBIOLOGY; MIDDLE AGED; NONPARAMETRIC TEST; PERIODONTICS; TOOTH PLAQUE;

ADULT; ANTI-INFECTIVE AGENTS, LOCAL; BACTERIA, ANAEROBIC; CHLORHEXIDINE; CHRONIC DISEASE; DELAYED-ACTION PREPARATIONS; DENTAL PLAQUE INDEX; DENTAL SCALING; DINOPROSTONE; FEMALE; GINGIVAL CREVICULAR FLUID; HUMANS; MALE; MIDDLE AGED; PERIODONTAL INDEX; PERIODONTAL POCKET; PERIODONTITIS; STATISTICS, NONPARAMETRIC;

EID: 33646341767     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2006.050105     Document Type: Article

References (38)

1. American Academy of Periodontology. Glossary of Periodontal Terms, 4th ed. Chicago: American Academy of Periodontology; 2001:40.
2. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6.
3. Haake SK, Nisengard RJ, Newman MG, Miyasaki KT. Microbial interactions with the host in periodontal diseases. In: Newman MG, Takei HH, Carranza FA, eds. Clinical Periodontology. Philadelphia: W.B. Saunders; 2002:132-152.
4. Ciancio SG. Systemic medications: Clinical significance in periodontics. J Clin Periodontol 2002;29(Suppl. 2): 17-21.
5. Slots J. Subgingival microflora and periodontal disease. J Clin Periodontol 1979;6:351-382.
6. Lundström A, Johansson LA, Hamp SE. Effect of combined systemic antimicrobial therapy and mechanical plaque control in patients with recurrent periodontal disease. J Clin Periodontol 1984;11:321-330.
7. Gusberti FA, Syed SA, Lang NP. Combined antibiotic (metronidazole) and mechanical treatment effects on the subgingival bacterial flora of sites with recurrent periodontal disease. J Clin Periodontol 1988;15:353-359.
8. Çetin EÖ, Buduneli N, Atlihan E, Kirilmaz L. In vitro studies on controlled-release cellulose acetate films for local delivery of chlorhexidine, indomethacin, and meloxicam. J Clin Periodontol 2004;31:1117-1121.
9. Killoy WJ. The use of locally delivered chlorhexidine in the treatment of periodontitis. Clinical results. J Clin Periodontol 1998;25:953-958.
10. Coventry J, Newman HN. Experimental use of a slow release device employing chlorhexidine gluconate in areas of acute periodontal inflammation. J Clin Periodontol 1982;9:129-133.
11. Soskolne WA, Chajek T, Flashner M, et al. An in vivo study of the chlorhexidine release profile of the PerioChip in the gingival crevicular fluid, plasma and urine. J Clin Periodontol 1998;25:1017-1021.
12. Stanley A, Wilson M, Newman HN. The in vitro effects of chlorhexidine on subgingival plaque bacteria. J Clin Periodontol 1989;16:259-264.
13. Soskolne WA, Heasman PA, Stabholz A, et al. Sustained local delivery of chlorhexidine in the treatment of periodontitis: A multi-center study. J Periodontol 1997;68:32-38.
14. Jeffcoat MK, Bray KS, Ciancio SG, et al. Adjunctive use of a subgingival controlled-release chlorhexidine chip reduces probing depth and improves attachment level compared with scaling and root planing alone. J Periodontol 1998;69:989-997.
15. Heasman PA, Heasman L, Stacey F, McCracken GI. Local delivery of chlorhexidine gluconate (PerioChip) in periodontal maintenance patients. J Clin Periodontol 2001;28:90-95.
16. Daneshmand N, Jorgensen MG, Nowzari H, Morrison J, Slots J. Initial effect of controlled release chlorhexidine on subgingival microorganisms. J Periodontal Res 2002;37:375-379.
17. Grisi DC, Salvador SL, Figueiredo LC, Souza SLS, Novaes AB, Grisi MFM. Effect of a controlled-release chlorhexidine chip on clinical and microbiological parameters of periodontal syndrome. J Clin Periodontol 2002;29:875-881.
18. 2 in a split mouth trial. J Clin Periodontol 2004;31:501-505.
19. Salmon JA, Riggs GA. Prostaglandins and leukotrienes as inflammatory mediators. Br Med Bull 1987;43: 285-296.
20. Ohm K, Albers HK, Lisboa BP. Measurement of eight prostaglandins in human gingival and periodontal disease using high pressure liquid chromatography and radioimmunoassay. J Periodontal Res 1984;19: 501-511.
21. 2 secretion as a determinant of periodontal disease expression. J Periodontol 1993;64: 432-444.
22. Offenbacher S. Periodontal diseases: Pathogenesis. Ann Periodontol 1996;1:821-878.
23. Rasmussen L, Hanström L, Lerner UH. Characterization of bone resorbing activity in gingival crevicular fluid from patients with periodontitis. J Clin Periodontol 2000;27:41-52.
24. Offenbacher S, Farr DH, Goodson JM. Measurement of prostaglandin E in crevicular fluid. J Clin Periodontol 1981;8:359-367.
25. Offenbacher S, Odle BM, Gray RC, Van Dyke TE. Crevicular fluid prostaglandin E levels as a measure of the periodontal disease status of adult and juvenile periodontitis patients. J Periodontal Res 1984;19: 1-13.
26. Löe H. The gingival index, the plaque index and retention index systems. J Periodontol 1967;38(Suppl.): 610-616.
27. Ainamo J, Bay I. Problems and proposal for recording gingivitis and plaque. Int Dent J 1975;25:229-235.
28. Quee TC, Bergeron MJ, Amsel R, Chan ECS. A staining method for monitoring subgingival bacteria associated with periodontal disease. J Periodontal Res 1986;21:722-727.
29. Jeffcoat MK, Palcanis KG, Weatherford TW, Reese M, Geurs NC, Flashner M. Use of biodegradable chlorhexidine chip in the treatment of adult periodontitis: Clinical and radiographic findings. J Periodontol 2000; 71:256-262.
30. Azmak N, Atilla G, Luoto H, Sorsa T. The effect of subgingival controlled-release delivery of chlorhexidine chip on clinical parameters and matrix metalloproteinase-8 levels in gingival crevicular fluid. J Periodontol 2002;73:608-615.
31. Ranney RR. Differential diagnosis in clinical trials of therapy for periodontitis. J Periodontol 1992;63:1052-1057.
32. Greenstein G, Berman C, Jaffin R. Chlorhexidine. An adjunct to periodontal therapy. J Periodontol 1986;57: 370-377.
33. Preshaw PM, Lauffart B, Zak E, Jeffcoat MJ, Barton I, Heasman PA. Progression and treatment of chronic adult periodontitis. J Periodontol 1999;70:1209-1220.
34. Ishihara Y, Nishihara T, Maki E, Noguchi T, Koga T. Role of interleukin-1 and prostaglandin in in vitro bone resorption induced by Actinobacillus actinomycetemcomitans lipopolysaccharide. J Periodontal Res 1991;26:155-160.
35. 2 on alveolar bone loss - Histometric analysis. J Periodontol 1992;63:405-411.
36. 2 levels as a predictor of periodontal attachment loss. J Periodontal Res 1986;21:101-112.
37. 2, and immunoglobulin G subclasses in gingival crevicular fluid in patients undergoing periodontal therapy. J Periodontol 1996;67:755-762.
38. 4 in the gingival crevicular fluid. J Dent 1998;26:97-103.